Esketamine protects against LPS-induced septic lung injury via NMDA receptor and NF-κB/NLRP3/Caspase-1/GSDMD pathway

International Immunopharmacology 2026

View at publisher

Authors: Qin Hu, Long Peng, Xueying Chen, Yun-chen Zhu, Li Zhang, Meng-yu Lu, Xiao-ming Deng, Jiafeng Wang

DOI: 10.1016/j.intimp.2026.117105

Cited by: 1

References: 37

Fields of Study & Subjects

Inflammasome and immune disorders Immune Response and Inflammation Immune cells in cancer

References 37